RecruitingNCT06866418

Phagenyx® Registry Study

Phagenyx® Registry Study: Evaluating Swallowing Therapy Outcomes and Recovery in the U.S.


Sponsor

Phagenesis Ltd.

Enrollment

600 participants

Start Date

Sep 15, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

A retrospective, open-label, matched-control registry study designed to characterize the effectiveness of Pharyngeal Electrical Stimulation (PES) to improve swallowing in patients with severe dysphagia post stroke when delivered using the Phagenyx® System in real-world clinical settings in hospitals in the United States of America (US).


Eligibility

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called 1. Phagenyx® System Group Patients for people with dysphagia. The study is currently recruiting participants at 2 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICE1. Phagenyx® System Group Patients

Patients who have undergone Pharyngeal Electrical Stimulation (PES) treatment for severe dysphagia using the Phagenyx® System


Locations(2)

HMH Jersey Shore University Medical Center

Neptune City, New Jersey, United States

University of Texas

Houston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06866418


Related Trials